By Lauren Hines | Bond LSC
During pregnancy, the fetus and mother can talk to each other without saying a word. On a deeper level, a special cell called the syncytiotrophoblast facilitates this conversation by changing the mother’s physiology based on what the fetus does or does not need.
The Michael Roberts lab at Bond Life Sciences Center knew there had to be other types of this essential cell. However, it wasn’t until postdoctoral fellow Teka Khan recently applied a method to analyze these cells that the lab found a new type of syncytiotrophoblast.
“It was, as you can see, a new discovery in the field of placental biology,” Khan said. “We identified at least two at this stage, two different kinds of nuclei which are in the syncytiotrophoblast…These nuclei belong to different syncytiotrophoblasts.”
These cells are responsible for gas exchange between the mother and the fetus — supplying oxygen via the placenta to the baby and disposing of carbon dioxide away from the fetus via circulation. It also produces a range of hormones including HCG, which helps maintain pregnancy. These cells line the placenta and lack many receptors and cell junctions commonly used by viruses to enter the cell, so in theory, they should be impenetrable to viruses.
“Anything that the syncytiotrophoblast is doing correctly or incorrectly could have a major impact on fetal development and then also how the maternal physiology is signaling,” said Megan Sheridan, postdoctoral fellow working with the Roberts lab.
Fully understanding these cells has been difficult due to their large size, fragility and their unusual 5-15 nuclei. Researchers usually use single-cell RNA sequencing to understand different cell types in the human placenta since most cells only have one nucleus. However, if they use this method on syncytiotrophoblasts, the cell will have to be broken to fit in the instrument and all the additional nuclei information would be lost.
Instead, Khan implemented a new method called single-nuclei RNA sequencing to analyze each individual nucleus.
“Before that, since people were doing single-cell RNA sequence, the syncytiotrophoblasts were … represented with very little information,” Khan said.
After using this method, Khan found two different nuclei clusters, indicating there were two different types.
The new type has a distinct difference in its nuclei and its gene expressions, which makes Khan believe they have different functions. However, it’s too early to say what those functions are.
Due to ethical and technical issues, researchers struggle to study the early stages of the human placenta. So, researchers use the BAP model of an early placenta to understand what’s going on in early pregnancy to eventually avoid disorders like miscarriages and preeclampsia. Better understanding this new type of syncytiotrophoblast and other placenta cells can bolster current models of the human placenta.
“Now we are doing the time course experiment of the same single nuclei RNA sequence using the same approach to see if we can identify how these cell types originate during the differentiation procedure and how they generate different kinds of cells,” Khan said. “This would definitely help us to understand the developmental process of the earliest stages of pregnancy and the placenta, especially the first two to three weeks of the placentation.”
Depending on the function of this new type, researchers could eventually create more targeted treatments.
“If [Khan] can then apply this to our preeclampsia models, then we could find signaling molecules that might be released by syncytiotrophoblast that is bad versus syncytiotrophoblast that’s good and see if we could find some sort of marker that would predict if the pregnancy might go wrong,” Sheridan said. “That’s way down the road, but that could be something.”
Now Khan is trying to find the functions of these two types and how he can apply this to the lab’s current model.
To learn more, read about single-nucleus RNA sequencing in Frontiers in Cell and Developmental Biology or about the BAP model used by the Roberts’ lab.